HALOTHANE HEPATITIS - DETECTION OF A CONSTITUTIONAL SUSCEPTIBILITY FACTOR

被引：67

作者：

FARRELL, G

PRENDERGAST, D

MURRAY, M

机构：

来源：

关键词：

D O I：

10.1056/NEJM198511213132102

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1310 / 1314

页数：5

共 29 条

[1] THE MECHANISM OF REDUCTIVE DEHALOGENATION OF HALOTHANE BY LIVER CYTOCHROME-P450
AHR, HJ
KING, LJ
NASTAINCZYK, W
ULLRICH, V
[J]. BIOCHEMICAL PHARMACOLOGY, 1982, 31 (03) : 383 - 390
[2] BIOTRANSFORMATION AND HEPATOTOXICITY OF HALOTHANE
BROWN, BR
SIPES, IG
[J]. BIOCHEMICAL PHARMACOLOGY, 1977, 26 (22) : 2091 - 2094
[3] CASCORBI HF, 1971, CLIN PHARMACOL THER, V12, P50
[4] METABOLISM OF HALOTHANE-2 14C IN MOUSE
COHEN, EN
[J]. ANESTHESIOLOGY, 1969, 31 (06) : 560 - &
[5] URINARY METABOLITES OF HALOTHANE IN MAN
COHEN, EN
TRUDELL, JR
EDMUNDS, HN
WATSON, E
[J]. ANESTHESIOLOGY, 1975, 43 (04) : 392 - 401
[6] HALOTHANE HEPATITIS - WHAT NEW
COUSINS, MJ
[J]. DRUGS, 1980, 19 (01) : 1 - 6
[7] DEGROOT H, 1983, HEPATOLOGY, V3, P601
[8] DIENSTAG JL, 1983, GASTROENTEROLOGY, V85, P439
[9] FARRELL GC, 1980, J BIOL CHEM, V255, P128
[10] GANDOLFI AJ, 1980, J PHARMACOL EXP THER, V214, P721